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Abstract
           Current pacing practice is undergoing continuous and substantial changes. Initially pacing 
had an exclusively palliative role, since it was reserved for patients developing complete heart 
block or severe symptomatic bradycardia. With the appearance of novel pacing indications such 
as pacing for heart failure and atrial fibrillation, the effect of pacing site on cardiac function has 
become a critically important issue and a subject for consideration. It seems that the classical 
pacing site  in  the  right  ventricular  apex is  no longer  the  gold standard because of  possible 
disadvantageous effects  on cardiac function.  The aim of this  review article is to discuss the 
effect of right ventricular apical pacing on cardiac function including cellular and hemodynamic 
changes.  We also  aim to discuss  the role  of  alternative pacing sites  in  the light  of  cardiac 
function. 
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Background:
            One of the most challenging tasks of modern pacing is to optimise or at least stabilize 
cardiac  performance.  This  is  clearly  dependent  on  the  important  factors  of  chronotropic 
function,  the  quality  of  AV  synchrony,  the  ventricular  activation  sequence  and  ventricular 
pacing site. Over the last 40 years stimulation of the right ventricular apex became the standard 
method for pacing the ventricles because it is a stable and easily accessible site, and usually 
provides appropriate sensing and threshold parameters1,2. Although it was quickly realised that 
stimulation of this site leads to an abnormal contraction pattern by bypassing the physiological 
conduction  system,  for  pacing  in  patients  with  life-threatening  conditions  it  still  seemed 
appropriate. However, with the widening of classical pacing indications and the realisation that 
some patients developed deterioration of left ventricular function and sometimes heart failure 
after  pacing,  it  became  the  subject  of  studies  into  its  effect  on  left  ventricular  function.  
            The aim of this review is to provide insights into understanding how the pacing site may 
influence cardiac function. This may have an impact on selection of alternative locations for the 
right ventricular lead when preservation or even improvement of left ventricular function seems 
to  be important  for  the patient.                                                         
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Endocardial  activation during right  ventricular  apical  pacing:                         
            During ventricular  pacing  the  impulse conduction occurs  predominantly  through the 
working myocardium and the normal conduction system is bypassed. During right ventricular 
pacing  the  right  ventricle  is  activated  first  followed  by  trans-septal  activation  of  the  left 
ventricle,  then  the  remaining  part  of  the  left  ventricle  is  activated.  The  QRS  duration  is 
increased, due to a combination of slow trans-septal activation (local and diffuse), and delayed 
activation  of  the remaining  part  of  the  left  ventricle  3.  A partial  comparison  can be  drawn 
between the endocardial activation of patients with right ventricular apical pacing and patients 
with  LBBB,  although  there  are  some  differences.  In  patients  with  LBBB,  endocardial 
breakthrough of right ventricular activation is on the right ventricular septum and this occurs 
earlier than left ventricular breakthrough4. This means that right ventricular activation in patients 
with LBBB is normal for most patients4.  Since in most patients the right ventricular lead is 
placed  more  antero-apically  than  septally,  clearly  the  endocardial  activation  during  right 
ventricular  apical  pacing  is  different,  resulting  in  a  more  superior  axis  and  even  more 
intraventricular delay during the activation of the right ventricle. On the other hand the left 
ventricle is still activated trans-septally in patients with right ventricular apical pacing, however 
left  ventricular  breakthrough  has  a  heterogeneous  pattern  in  these  patients,  resulting  in  a 
somewhat  different  activation  pattern to  that  observed during  LBBB.  In most  patients  with 
LBBB high septal breakthrough is most common4, whereas in most patients during RV apical 
pacing a single site of left ventricular breakthrough close to the ventricular apex is found. The 
presence of structural heart disease such as previous myocardial infarction may further increase 
the QRS duration during right ventricular apical pacing5. The effects of pacing site will also be 
different  depending on whether  intrinsic  AV node conduction and thus  fusion of  activation 
patterns,  is  present6,7.                                 
Effect  of  right  ventricular  apical  pacing  on  the  structure  and  function of  the  heart:  
            For many years the attention given to optimising the atrio-ventricular delay during dual 
chamber pacing has delayed an understanding of the importance of the effect of pacing site on 
global and regional  myocardial  function.  This is  despite the fact  that  diminished ventricular 
function during pacing at the right ventricular apex has been known for decades from numerous 
animal  and  human  studies  8,9,10.  Ventricular  pacing  results  in  an  abnormal  sequence  of 
activation  and  this  is  associated  with  decreases  in  fiber  shortening,  contractile  work,  and 
myocardial blood flow and oxygen consumption in regions activated early and increases in these 
parameters in those regions with delayed activation 11,12,13. Studies have also confirmed that the 
early-activated regions are hypofunctional and the late activated regions are hyperfunctional. 
These  differences  are  due  to  regional  alterations  in  effective  preload  during  asynchronous 
activation.  The ventricular  wall  has to  adapt  to  these changes.  The asynchronous activation 
induces asymmetrical hypertrophy of the left ventricular wall. This asymmetric hypertrophy in 
itself however does not primarily influence the pump function. Abnormal electrical activation 
may thus lead to depressed left ventricular function12 by the classical theory of "loss of effective 
muscle mass". According to this theory, during ventricular pacing the ventricle looses a part of 
its effective muscle mass due to reduced function of the early-activated regions. An alternative 
or probably additional mechanism is that RV apical pacing results in inferior interventricular 
coupling, since during RV pacing the right ventricular pressure rises much earlier than that in 
the LV and this causes significant paradoxical  septal  motion10.                             
            Experimental animal data have also indicated that right  ventricular  apical  pacing may 
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decrease  regional  myocardial  blood  flow within  the  interventricular  septum14,15.  Prolonged 
compression  of  the  septal  arteries,  as  a  result  of  the  altered  left  ventricular  depolarisation 
sequence was proposed as a possible explanation14,16. Extravascular compression is also a well-
known  determinant  of  coronary  blood  flow  during  the  basal  state  or  during  coronary 
vasodilation17. There is evidence, that aberrant and delayed depolarisation of the left ventricle 
can  result  in  augmented  intra-myocardial  pressure  in  the  septum,  thus  significantly  affect 
myocardial perfusion in this region16. These animal data have been confirmed by human studies, 
where  atrial  and/or  AV  sequential  pacing  did  not  alter  coronary  flow  reserve,  however 
ventricular pacing decreased resting coronary flow velocity in some patients18.  Furthermore, 
long term right ventricular apical pacing results in a high incidence of myocardial perfusion 
defects  on  nuclear  studies.  The magnitude  of  these defects  was  linearly  proportional  to  the 
duration of pacing 19. These myocardial perfusion abnormalities are associated with apical wall 
motion abnormalities and impaired global left ventricular function19.  Ventricular pacing also 
results  in  regional  changes  in  tissue  perfusion  and  heterogeneity  between  perfusion  and 
sympathetic  innervation20.  Both  ventricular  and  dual  chamber  pacing  are  associated  with 
increase in cathecolamine activity20. Furthermore, so-called functional mitral regurgitation plays 
a crucial role in suboptimal hemodynamics. Right ventricular apical pacing causes significant 
intraventricular conduction delay. Segments of the left and right ventricle contract at different 
times and the interventricular  septal  wall  contracts  abnormally.  This  phenomenon results  in 
decreased contractility, reduced diastolic filling and prolonged duration mitral regurgitation. The 
abnormal activation of the ventricles via right ventricular apical pacing may result in multiple 
abnormalities  of  cardiac  function,  which  may  ultimately  affect  clinical  outcome.   
Chronic  pacing  of  the  right  ventricular  apex  for  symptomatic  bradycardia    
            Acute clinical studies show that atrial pacing with preserved atrio-ventricular conduction 
and normal intraventricular conduction ensure better pump function at rest and a low pacing 
rates than DDD pacing with a restricted AV interval 21. Because of the lack of long term follow 
up these findings were not confirmed by clinical studies. On the other hand evidence has been 
growing that pacing at alternative pacing sites improves function and influences outcome as 
well22,23,24. The maintenance of atrio-ventricular synchrony is a critically important issue for 
these patients25.  The risk of atrial arrhythmias and thrombo-embolic complications is clearly 
higher in VVIR paced patients than in AV sequentially or AAI paced patients specifically if AV 
conduction is preserved26. VA conduction is has been documented in 75% of the patients with 
SSS  and  even  in  more  than  50%  of  the  patients  with  complete  AV  block  27.  Therefore 
maintenance of AV synchrony prevents "pacemaker syndrome". Improved exercise tolerance 
was also reported. Patients with SSS and VVI pacing are more likely to develop heart failure 
than with AAI pacing  26,28. One of the key targets of pacing therapy apart from mortality is 
improved QOL. Initially, DDD pacing seemed to be of most benefit in patients with high degree 
AV block and preserved sinus node function 29. However this hypothesis was not confirmed by 
recent multicenter study. Patients with SSS had more benefit from DDD pacing compared with 
VVI pacing, than patients with complete AV block 30. Another important issue, that may explain 
the controversial  clinical  data is related to the duration of right ventricular apical pacing.  It 
seems that a longer duration of right ventricular pacing results in a more myocardial perfusion 
abnormalities19.  Interestingly,  this  phenomenon seems to  be  reversible  even after  two years 
pacing 19,31. The duration of right ventricular pacing was also associated with the magnitude of 
decreased left ventricular ejection fraction. The reduced ejection fraction is mainly caused by an 
increased  left  ventricular  end-systolic  volume.                            
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Left ventricular function after AV node ablation and right ventricular apical pacing for 
patients  with  permanent  atrial  fibrillation:  Discordant  evolution  of  subjective  and 
objective  parameters                                   
            Patients  with  permanent  atrial  fibrillation  undergoing  AV  node  ablation  and  VVIR 
pacemaker implantation are optimal subjects for studying the effect of right ventricular apical 
pacing on left  ventricular  function for  two reasons.  First  of  all,  these  patients  have no AV 
conduction, therefore the effect of AV delay does not influence the results; the effect of pacing 
site on the function could be studied independently. The other obvious reason is related to the 
concept of tachycardiomyopathy32. A relatively large proportion of these patients are suffering 
for  a  long  time  from  permanent  atrial  fibrillation.  Atrial  fibrillation  is  a  common 
supraventricular arrhythmia, which leads to cardiac dilatation and dysfunction in some patients - 
tachycardiomyopathy32. Theoretically, and practically in the majority of patients, ablation of the 
atrio-ventricular node followed by right ventricular apical pacing may result in an improvement 
of the patient's symptoms as well as in cardiac function because of the advantage of a regular 
ventricular response and adequate rate control32,33,34,35. However, variable results were reported 
about the course of patients following AV junction ablation. Although noticeable improvement 
in QOL has been reported, some other studies reported not improved or sometimes decreases left 
ventricular  function34,36,37.  An  important  aspect  of  these  controversial  data  is  that  in  most 
available large studies only data on the overall group was reported, despite the obvious fact that 
some patients deteriorated. After careful analysis of the data extracted from these studies, it 
seems that during the follow up, objective and subjective parameters showed somewhat of a 
discordant  evolution.  Correct  interpretation  of  this  data  may  allow  us  to  develop  a  better 
understanding of the natural course of these patients and the reasons for this discordance. After 
AV node ablation  numerous  factors  are  influencing  LV function.  Some of  them act  in  the 
direction  of  improvement,  but  some  of  them  may  cause  deterioration.  Regularisation  and 
ventricular rate control appear to be the most important factors that may have an impact on 
improvement.  On  the  other  hand  right  ventricular  apical  pacing  results  in  disadvantageous 
cellular changes and worsened hemodynamics. It seems so far, that the net effect of interplay 
between  the  beneficial  and  the  worsening  factors  is  unpredictable.  The  almost  uniform 
improvement in quality of life supports the idea that subjective parameters are more influenced 
by the beneficial factors, however function react independently. In some patients, concordant 
with the QOL, function improves, however in others, despite the improvement in QOL, it may 
deteriorate. Therefore, in symptom control, regularisation and rate control are important factors, 
but  their  role  in  functional  changes  are  not  that  clear.  This  variable  outcome is  of  clinical 
significance  as  per  the  important  question  of  Wood,  as  to  whether  AV  node  ablation  is 
applicable to a wider spectrum of patients37. According to our experience and unpublished data 
we think that  the effect of AV node ablation and right ventricular apical  pacing on cardiac 
function is  highly dependent  on the baseline  left  ventricular  ejection fraction.  It  seems that 
patients with preserved left ventricular function will more likely deteriorate their left ventricular 
function. Therefore, this therapy should be avoided in patients where only symptom control is 
the goal and who have normal cardiac function. This is in concordance with the concept of 
tachycardiomypoathy. It seems, that AV node ablation and right ventricular apical pacing is the 
best  for  patients  with  tachycardiomyopathy32.                          
Alternative pacing sites for preservation of left ventricular function: The possible role of 
high ventricular, left ventricular and biventricular pacing                                 
            As shown in previous trials, pacing of the right ventricular apex (the traditional   pacing 
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site) reduces LV function more than pacing the high ventricular septum or at LV sites8,9,38. 
Since pacing of these alternate sites results in a narrowed QRS complex as compared to RV 
apical  pacing,  synchronisation of  electrical  activation of  the two ventricles  seems to have a 
certain level of importance7,24. However, in some studies LV pacing without reduction of the 
QRS duration was more beneficial  than biventricular pacing with marked reduction in QRS 
duration10. The study of Prinzen et al. showed improved hemodynamics with high ventricular 
septum  pacing6,  while  Blanc  and  colleagues  demonstrated  improvement  with  LV  pacing 
compared with RV apical pacing39.  Biventricular pacing had a similar effect39.  Interestingly 
enough, LV pacing alone was sufficient to improve LV function39. We can conclude from these 
studies that the pacing site probably has more influence on LV function than changes in the 
activation  sequence  itself.  Certainly  all  of  these  studies  were  acute  hemodynamic  studies; 
therefore correlation with long-term results is still to be investigated. The mechanism of this 
action stems from the classical theory of "loss of effective muscle mass". According to this 
theory, during ventricular pacing the ventricle looses a part of its effective muscle mass due to 
reduced  function  of  the  early  activated  regions.  Studies  confirmed  that  the  early-activated 
regions are hypofunctional and the late activated muscles are hyperfunctional. This results in a 
substantial degree of asynchrony. An alternative mechanism is that left ventricular pacing results 
in a superior interventricular coupling. During RV pacing the right ventricular pressure rises 
much earlier  than during LV pacing and causes a  significant paradoxical  septal  motion  10.  
            In conclusion, the ventricular pacing site has a major effect on ventricular function. It 
influences  hemodynamics,  initiates  cellular  changes  and  alters  myocardial  perfusion.  These 
changes might result in left ventricular dysfunction in a considerable number of patients. Since 
the patients who develop dysfunction with pacing cannot be predicted according to our present 
knowledge, selection of alternative pacing sites, when the preservation and improvement of left 
ventricular  function  is  important,  should  be  considered  during  the  routine  clinical  practice.
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